No results for ‘’
Lincoln Pharmaceuticals Ltd
₹705.20
(0.72%)
Wed, 27 May 2026, 00:03 pm
Health Technology
Pharmaceuticals: Major
24.5KLincoln Pharmaceuticals Shareholding
| Shareholders | MAR 2026 | DEC 2025 | SEPT 2025 | JUN 2025 | MAR 2025 |
|---|---|---|---|---|---|
| Promoters | 49.78 | 49.78 | 49.78 | 49.78 | 49.78 |
| FII | 5.19 | 4.70 | 4.72 | 5.14 | 5.00 |
| DII | 1.09 | 0.01 | 0.01 | 0.01 | 0.01 |
| Public | 43.94 | 45.52 | 45.49 | 45.07 | 45.22 |
| Government | 0 | 0 | 0 | 0 | 0 |
Lincoln Pharmaceuticals Ltd Shareholding Pattern
The Lincoln Pharmaceuticals Ltd shareholding pattern provides detailed insights into how ownership of the company is distributed among promoters, FIIs, DIIs, public investors, and government entities. Tracking the Lincoln Pharmaceuticals Ltd shareholding structure helps investors understand institutional confidence, promoter commitment, and overall market sentiment.
Lincoln Pharmaceuticals Ltd (NSE: LINCOLN, BSE: 531633) operates in the Health technology sector and Pharmaceuticals: major industry. Monitoring the Lincoln Pharmaceuticals Ltd shareholding pattern regularly allows investors to analyze ownership trends and make informed investment decisions.
Lincoln Pharmaceuticals Ltd Shareholding Pattern (Latest)
The latest Lincoln Pharmaceuticals Ltd shareholding for Mar 2026 is:
- Promoters: 49.78%
- FII: 5.19%
- DII: 1.09%
- Public: 43.94%
- Government: 0%
Promoter holding in Lincoln Pharmaceuticals Ltd remains stable, reflecting consistent long-term commitment.
Lincoln Pharmaceuticals Ltd Promoter Holding Trend
Promoter shareholding plays a crucial role in evaluating management confidence in Lincoln Pharmaceuticals Ltd.
- Mar 2026: 49.78%
- Dec 2025: 49.78%
- Sept 2025: 49.78%
- Jun 2025: 49.78%
- Mar 2025: 49.78%
Promoter stake remains largely stable, showing consistent ownership structure.
Lincoln Pharmaceuticals Ltd FII Shareholding Trend
Foreign Institutional Investors (FIIs) reflect global investor sentiment toward Lincoln Pharmaceuticals Ltd.
- Mar 2026: 5.19%
- Dec 2025: 4.70%
- Sept 2025: 4.72%
- Jun 2025: 5.14%
- Mar 2025: 5.00%
FII holding in Lincoln Pharmaceuticals Ltd has increased recently, indicating rising foreign investor interest.
Lincoln Pharmaceuticals Ltd DII Shareholding Trend
Domestic Institutional Investors (DIIs) include mutual funds, banks, and insurance companies.
- Mar 2026: 1.09%
- Dec 2025: 0.01%
- Sept 2025: 0.01%
- Jun 2025: 0.01%
- Mar 2025: 0.01%
DII stake in Lincoln Pharmaceuticals Ltd has increased over time, indicating growing domestic institutional confidence.
Lincoln Pharmaceuticals Ltd Public Shareholding Trend
Public shareholding represents retail and non-institutional investors.
- Mar 2026: 43.94%
- Dec 2025: 45.52%
- Sept 2025: 45.49%
- Jun 2025: 45.07%
- Mar 2025: 45.22%
Public holding remains stable with consistent retail participation.
Lincoln Pharmaceuticals Ltd Government Holding
Government holding in Lincoln Pharmaceuticals Ltd currently stands at 0%.
Lincoln Pharmaceuticals Ltd operates without significant government ownership.
Lincoln Pharmaceuticals Ltd Shareholding Analysis Summary
The Lincoln Pharmaceuticals Ltd shareholding pattern highlights the ownership structure and investor confidence in the company. Stable promoter holdings combined with institutional participation often indicate strong fundamentals and long-term growth potential.
Investors should monitor changes in Lincoln Pharmaceuticals Ltd shareholding for signals on institutional sentiment and ownership trends.
Regular monitoring of the Lincoln Pharmaceuticals Ltd shareholding helps investors understand market confidence, institutional activity, and potential future stock movements.